Trial | NCT01020162  Report issue

Title

Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain
Treatment of Ilioinguinal Entrapment Syndrome - a Randomised Controlled Trial

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    amitriptyline gabapentin ...

  • Study Participants

    19
Neuralgic pain caused by entrapment of peripheral nerves is an often overlooked cause of chronic pelvic pain. The objective of the present study was to assess pain and quality of life in women with pain caused by entrapment of the ilioinguinal nerve, iatrogenic after surgery but also found without previous surgery. In a controlled prospective cross-over study 19 women were randomized either to medical treatment or to resection of the nerve. Statistically significant improvements were found after surgical resection.
Study Started
Sep 30
1995
Primary Completion
Dec 31
2006
Study Completion
Nov 30
2007
Last Update
Nov 25
2009
Estimate

Drug Amitryptiline, gabapentin

For amitryptiline starting dose 20-30 mg at night, increasing until clinical effect. For gabapentin was the initial dose 300 mg tid with rapid increases up to 800 mg tid.

  • Other names: Amitryptiline - Saroten, Gabapentin - Neurontin

Procedure Resection of the ilioinguinal nerve

In general anaesthesia the nerve was identified and resected as central as possible

Non-surgical Active Comparator

TENS, amitriptyline, gabapentin.

Surgical intervention Active Comparator

Resection of the ilioinguinal nerve

Criteria 

Inclusion Criteria:

Pelvic pain in which a careful investigation has shown signs of ilioinguinal nerve entrapment

Exclusion Criteria:

Drug abuse
No Results Posted